CEO Anthony Davies had the distinct honor of being on the panel for the inaugural episode of Phacilitate: Talks, a socially-distanced podcast for the Cell & Gene Therapy space. Click on the image to be taken out to the podcast …

Cell and Gene Therapies Get a Reality Check: A Conversation with Anthony Davies of Dark Horse Consulting Group

As founder of cell and gene therapy (CGT) specialist firm Dark Horse Consulting Group in California, Anthony Davies speaks from a quarter …

This on-demand Cell & Gene Therapy Insights webinar from BioInsights is available…well, on demand. So, anytime you’d like, you can check out information on regulatory FAQs & common concerns for C&GT raw and starting materials by clicking here. Featuring our …

By Robert Allen, Ph.D.

Get organised and get smart. The virtual audit: Ensuring quality and compliance during the current global pandemic Learn more about this offering

Executive summary of Dark Horse Consulting Group’s April 2020 Whitepaper

Current global circumstances prevent

…

By Nathan Manley & Katy Spink

The cell therapy field is currently in an exciting era of expansion, with a large number of candidate therapies advancing into clinical testing and many more progressing through preclinical pipelines. As the number of …

by Gareth Macdonald

The cell therapy sector faces a cost of goods sold (COGS) crisis and needs to get beyond the “product is the process” mind-set says Anthony Davies, CEO of Dark Horse Consulting.

Cell and gene therapies have attracted …

by Katy Spink & Andrew Steinsapir

With the 2017 FDA approvals and launches of the first gene-modified cell and pure-play gene therapy products to gain licensure in the United States, increasing attention has been paid to the high cost of …